欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号SE/H/1262/001
药品名称Gemcitabin Mylan
活性成分
    • gemcitabine hydrochloride 10.0 mg/ml
剂型Concentrate for solution for infusion
上市许可持有人Mylan Hospital AS Norway
参考成员国 - 产品名称Sweden (SE)
互认成员国 - 产品名称
    • United Kingdom (Northern Ireland) (XI)
许可日期2013/07/04
最近更新日期2017/06/28
药物ATC编码
    • L01BC05 gemcitabine
申请类型
  • TypeLevel1:Abridged
  • TypeLevel2:Initial Application
  • TypeLevel3:Other Generic application Art 10.3 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase